Typefaces

Myriad Genetics to Release Second Quarter Financial Results on August 3, 2021

Retrieved on: 
Wednesday, July 28, 2021

SALT LAKE CITY, July 28, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it will hold its quarterly earnings conference call for the quarter ended June 30, 2021, at 4:30 p.m. EDT on Tuesday, August 3, 2021.

Key Points: 
  • SALT LAKE CITY, July 28, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it will hold its quarterly earnings conference call for the quarter ended June 30, 2021, at 4:30 p.m. EDT on Tuesday, August 3, 2021.
  • The companys quarterly earnings will be released prior to the market opening on August 3, 2021.
  • During the call, Paul J. Diaz, president and CEO, and R. Bryan Riggsbee, chief financial officer, will provide a financial overview and business update of Myriad Genetics performance for the second quarter of 2021.
  • Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, Vectra, EndoPredict, Prequel, Foresight, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries.

MasterClass Announces First Painting Class with Futura

Retrieved on: 
Thursday, July 22, 2021

Futura's class is now available exclusively on MasterClass , where subscribers get unlimited access to all 100+ instructors with an annual membership.

Key Points: 
  • Futura's class is now available exclusively on MasterClass , where subscribers get unlimited access to all 100+ instructors with an annual membership.
  • "I'm excited to teach and impart wisdom and skills that I've learned from the last 50 years of painting outside the lines," Futura said.
  • In celebration of Futura's class launch, MasterClass and Futuravia his commercial product brand Futura Laboratorieshave partnered to create a t-shirt capsule that features exclusive artwork from Futura's class.
  • MasterClass will reward the first 100 members who complete Futura's class with a t-shirt from the collection.

Tahoma Engineered Solutions Promotes Michele Gesing to Production Scheduler

Retrieved on: 
Thursday, July 22, 2021

ASHLAND, Ohio, July 22, 2021 /PRNewswire/ -- Tahoma Engineered Services, a leading manufacturer of precision machined parts and wire formed products, recently promoted Michele Gesing into the position of Production Scheduler.

Key Points: 
  • ASHLAND, Ohio, July 22, 2021 /PRNewswire/ -- Tahoma Engineered Services, a leading manufacturer of precision machined parts and wire formed products, recently promoted Michele Gesing into the position of Production Scheduler.
  • "One of her first projects in this role will be implementing the advanced scheduler portion of our management software system."
  • Before joining Tahoma Engineered Services, Gesing gained more than 10 years of professional experience in working in a manufacturing environment.
  • Tahoma Engineered Solutions, a business unit of Tahoma Enterprises, is ISO 9001-2015 certified.

Immuneering Appoints Michael Bookman as General Counsel and Secretary

Retrieved on: 
Tuesday, July 20, 2021

CAMBRIDGE, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Immuneering Corporation (Immuneering), a private biopharmaceutical company advancing a robust pipeline of oncology and neuroscience drug candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced the appointment of Michael Bookman to the newly created position of General Counsel and Secretary, effective immediately.

Key Points: 
  • CAMBRIDGE, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Immuneering Corporation (Immuneering), a private biopharmaceutical company advancing a robust pipeline of oncology and neuroscience drug candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced the appointment of Michael Bookman to the newly created position of General Counsel and Secretary, effective immediately.
  • We are delighted to welcome him to the Immuneering team, stated Ben Zeskind, Ph.D., Co-Founder and Chief Executive Officer of Immuneering.
  • I look forward to working with this dynamic management team to build Immuneering into a leading biopharmaceutical company, said Mr. Bookman.
  • Mr. Bookman joins Immuneering from Frequency Therapeutics (Frequency), where he served as General Counsel and Secretary since 2019.

Monotype Introduces Helvetica Now Variable Font, Including Over 1 Million New Styles

Retrieved on: 
Tuesday, July 13, 2021

Monotype today introduced Helvetica Now Variable, offering over a million new Helvetica Now styles in one state-of-the-art font file.

Key Points: 
  • Monotype today introduced Helvetica Now Variable, offering over a million new Helvetica Now styles in one state-of-the-art font file.
  • Helvetica Now Variable builds on the 2019 release of Helvetica Now , which reimagined the clarity, simplicity and neutrality of classic Helvetica with 21st-century design needs including optical sizing, stylistic alternates and an extended character set.
  • The incredibly positive reception to Helvetica Now makes us proud to build upon this time-tested design even further, said Charles Nix, Creative Type Director at Monotype.
  • Moreover, its just plain fun, with the potential to bring the good news of variable fonts to the masses.

Myriad Genetics Completes Sale of Myriad RBM to IQVIA’s Q2 Solutions

Retrieved on: 
Thursday, July 1, 2021

SALT LAKE CITY, July 01, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has completed the sale of its wholly-owned subsidiary, Myriad RBM, Inc. to Q2 Solutions, a leading global clinical trial laboratory services organization, and a wholly owned subsidiary of IQVIA.

Key Points: 
  • SALT LAKE CITY, July 01, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has completed the sale of its wholly-owned subsidiary, Myriad RBM, Inc. to Q2 Solutions, a leading global clinical trial laboratory services organization, and a wholly owned subsidiary of IQVIA.
  • Q2 Solutions provides comprehensive testing, project management, supply chain, biorepository, biospecimen and consent tracking solutions.
  • Myriad RBM, which specializes in laboratory services for clinical research for the pharmaceutical industry, will be added to the overall Q2 Solutions menu and offerings.
  • Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, Vectra, EndoPredict, Prequel, Foresight, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries.

Sorrento Receives EUA Approval and Import License From Mexico Authority COFEPRIS For COVI-STIX™ (COVID-19 Virus Rapid Antigen Detection Test) and Plans Product Launch With Initial Shipments in July

Retrieved on: 
Thursday, June 24, 2021

Sorrento received official EUA registration and product import license: COFEPRIS EUA registration number OFICIO: CAS/10720/2021.

Key Points: 
  • Sorrento received official EUA registration and product import license: COFEPRIS EUA registration number OFICIO: CAS/10720/2021.
  • Sorrento is establishing its Sorrento Mexico Ltd subsidiary to enable commercialization of COVI-STIX and future COVID-19 related products in the country.
  • Sorrento expects the first shipments for initial COVI-STIX test orders to be delivered in July.
  • Sorrento will commercially launch the COVI-STIX test in Mexico with the first shipments expected to be delivered in July.

GetSwift Announces Departure of Dennis Noto

Retrieved on: 
Friday, June 11, 2021

GetSwift Technologies Limited (NEO:GSW) (GetSwift or the Company), a leading provider of last mile SaaS logistics technology and services, is announcing the departure of Dennis Noto, Chief Technology Officer.

Key Points: 
  • GetSwift Technologies Limited (NEO:GSW) (GetSwift or the Company), a leading provider of last mile SaaS logistics technology and services, is announcing the departure of Dennis Noto, Chief Technology Officer.
  • Mr. Noto was hired in 2018 with the mandate to develop GetSwift's technology to an enterprise grade platform and architecture.
  • We would like to thank Mr. Noto for his contribution to the development of GetSwifts technology and wish him well in his future endeavours.
  • As a result of his departure, Mr. Noto is no longer an Insider (as defined in the NEO Listing Manual) of the Company.

benjamin Receives Multiple 2021 Industry Recognition, Awards and Accolades

Retrieved on: 
Wednesday, June 9, 2021

ATLANTA, June 9, 2021 /PRNewswire-PRWeb/ -- benjamin, the only business support system driven by AI and specifically designed for the wealth management industry, announced today that the firm has been named a two-time Finalist in the 2021 wealthmanagement.com "Wealthies" Industry Awards Program, the only awards program of its kind to honor outstanding achievements by companies, organizations and individuals that support financial advisor success.

Key Points: 
  • ATLANTA, June 9, 2021 /PRNewswire-PRWeb/ -- benjamin, the only business support system driven by AI and specifically designed for the wealth management industry, announced today that the firm has been named a two-time Finalist in the 2021 wealthmanagement.com "Wealthies" Industry Awards Program, the only awards program of its kind to honor outstanding achievements by companies, organizations and individuals that support financial advisor success.
  • More than 900 entries were received from 346 companies, an increase of over 40% from previous years.
  • Additionally, benjamin CEO Matt Reiner was named to the 2021 InvestmentNews "40 Under 40" List.
  • benjamin elegantly automates a myriad of time-consuming and menial yet imperative tasks, providing the advisor more time to foster value-added client relationships.

Dee Baskerville Promoted to Program Manager at Counter Threat Solutions

Retrieved on: 
Wednesday, June 2, 2021

RESTON, Va., June 2, 2021 /PRNewswire/ --Reston-based consulting firm Counter Threat Solutions LLC (CTS) announced that Demetrice (Dee) Baskerville has been promoted to Program Manager.

Key Points: 
  • RESTON, Va., June 2, 2021 /PRNewswire/ --Reston-based consulting firm Counter Threat Solutions LLC (CTS) announced that Demetrice (Dee) Baskerville has been promoted to Program Manager.
  • In this role, Baskerville will oversee the management and growth of key government contracts as well as the professional development of a cadre of CTS employees.
  • Baskerville joined CTS in 2020 and quickly earned a reputation for stellar client service.
  • Counter Threat Solutions LLC (CTS) is a Woman-Owned Service-Disabled Veteran-Owned Small Business (SDVOSB) consulting company providing mission-savvy subject matter experts skilled in analysis, finance, multimedia, administrative support, program management, and IT solutions to the U.S. government's intelligence and defense communities as well as commercial clientele.